Skip to content

Anti-inflammatory treatment or observation of pulmonary ground glass nodules: A multicenter prospective cohort study

Anti-inflammatory treatment or observation of pulmonary ground glass nodules: A multicenter prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056975
Enrollment
Unknown
Registered
2022-02-25
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary ground glass nodules

Interventions

Anti-inflammatory treatment group:

Sponsors

Jiangyou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years; 2. Pulmonary ground glass nodules with a maximum nodule diameter > 5 mm and <= 20 mm when first detected by chest CT; 3. Clinical consideration that surgery is not required for the time being; 4. Willing to participate in this study.

Exclusion criteria

Exclusion criteria: 1. The nodule was first detected > 2 weeks ago; 2. Antibiotics had been used within 2 weeks prior to enrollment.

Design outcomes

Primary

MeasureTime frame
Patient response rate at first follow-up (effective patients/total patients);

Secondary

MeasureTime frame
Nodule response rate at first follow-up (effective nodule/summary segment);

Countries

China

Contacts

Public ContactWenhong Feng

Jiangyou People's Hospital

154060383@qq.com+86 15882888010

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026